The IV and oral DMPK profiles of compounds 3, 4, 10, 16, and 23 were evaluated in a 1 mg/Kg cassette dose experiment in C57Bl/6 mice.
Four of the compounds demonstrated essentially identical profiles with short half-lives, high clearance, and low oral bioavailability. Compound 4 (GSK2945) was differentiated from the group with a longer half-life of 2.0 h and an oral bioavailability of 23%, despite the higher cLogP of the compound (Table 2 and Supporting Information Figure 4).
[...]
The remaining four compounds (3, 10, 16, 23) would be suitable for acute time-of-day dosing by injection where short exposure of the compound at meaningful levels in desired
-------
Sr9009 is #3
Even the most promising #4 only had 2hr half life an oral bioavailability of 23%.
So sr9009 is even less.
1mg/kg
So a 150lb person taking 150mg of the promising compound at 23% would only get you around 34mg to last a couple hours then you'd want to dose another 150...
With sr9009, you'd get even less, with less time in the system
Invalid Link Removed
In case you want to read the 112 page study
.